The moves follow the passing of President Joe Biden's Inflation Reduction Act last year that capped insulin prices for Medicare recipients at $35 per month, but does not include patients without insurance. and Canada insulin market as of November, also said it would reduce the list price of unbranded insulin products to match lowered prices of respective branded insulin products. See here for a complete list of exchanges and delays